Trial
NCT02874820
I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
GlaxoSmithKline
Condition
Alzheimer Disease
Intervention
[11C]BU99008
Why stopped
Patient recruitment issues.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-27